Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – Bezafibrate, a pan-PPAR agonist used widely for treating dyslipidemia in the UK, appears to prevent or delay the development of type 2 diabetes,…
NEW YORK (Reuters Health) – The results of a new study suggest that tuberculosis may be cured faster by adding moxifloxacin to a standard TB treatment protocol than…
NEW YORK (Reuters Health) – The results of a placebo-controlled trial suggest that controlled-release oxycodone is an effective treatment for acute pain due to herpes zoster, whereas gabapentin…
NEW YORK (Reuters Health) – For the management uncomplicated hypertension, using initial low-dose, fixed-dose combination therapy is better than guideline-based treatment, according to a report in the April…
NEW YORK (Reuters Health) – Consolidation therapy with low-dose thalidomide and prednisolone can improve survival in patients with multiple myeloma who have undergone autologous stem-cell transplantation (ASCT), according…
NEW YORK (Reuters Health) – In patients with upper-extremity spasticity due to stroke or traumatic brain injury (TBI), botulinum toxin injections are safer and more effective than oral…
NEW YORK (Reuters Health) – In patients with chronic hepatitis C genotype 4, adding nitazoxanide to peginterferon alfa-2a and ribavirin improves the virologic response rates, new research shows.…
NEW YORK (Reuters Health) – The use of aspirin as a cardioprotective agent significantly reduces recurrence among patients being treated for high-grade, non-muscle-invasive bladder cancer, the results of…
NEW YORK (Reuters Health) – Using a novel high-throughput screening assay, a team of scientists has discovered that two highly virulent viruses are susceptible in vitro to the…
NEW YORK (Reuters Health) – Nortriptyline is more effective than paroxetine CR in reducing symptoms of depression in patients with Parkinson’s disease, according to results of a small…
